Pilot Study to Evaluate Right Ventricular Function With Riociguat in CTEPH

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Chronic Thromboembolic Pulmonary Hypertension
Interventions
RADIATION

Cardiac PET imaging using F-18-FDG, N-13 ammonia( NH3)

After an overnight fast, patients will undergo a 20 minute dynamic PET scan with injection of 3 MBq/kg of N-13 ammonia (NH3) to measure myocardial perfusion. Followed by a 60 min dynamic PET scan with injection of 3MBq/kg of F-18-FDG to measure glucose uptake.

Trial Locations (1)

K1Y4W7

University of Ottawa Heart Institute, Ottawa

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Ottawa Heart Institute Research Corporation

OTHER